Kathrin Strasser-Weippl, Gautam Sudan, Ravi Ramjeesingh, Lois E. Shepherd, Joyce O'Shaughnessy, Wendy R. Parulekar, P Liedke, Bingshu E. Chen, Paul E. Goss. Read more about what the tomato flu virus is, how you can catch it and what we know about treatment so far. . Overview. The bible may speak about the same things but mix in a whole lot of other things which can send you mad, if there is anything in life that is going wrong or you don't like get this book and trust me the truth hurts. Breast cancer adjuvant endocrine therapy. WASHINGTON D.C. - U.S. Representative Paul Gosar, D.D.S. Hadine Joffe, Ann H. Partridge, Anita Giobbie-Hurder, Xiaochun Li, Karleen Habin, Paul E. Goss, Eric P. Winer, Judy Garber, A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women, Tessa Cigler, Dongsheng Tu, Martin J. Yaffe, B. Findlay, Shailendra Verma, D. Johnston, Harriet Richardson, Haiqing Hu, Shangle Qi, Paul E. Goss. His net worth has been growing significantly in 2021-2022. Frances A. Shepherd, Robert J. Ginsberg, G.A. Frances A. Shepherd, Jennifer Laskey, William K. Evans, Paul E. Goss, Else Johansen, Firouz Khamsi. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Joseph Gligorov, Kathleen I. Pritchard, Paul E. Goss, National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women, Paul E. Goss, Harriet Richardson, Rowan T. Chlebowski, D. Johnston, Gloria E. Sarto, Elizabeth Maunsell, James N. Ingle, Jos E. Als-Martnez, Phase III, Double-Blind, Controlled Trial of Atamestane Plus Toremifene Compared With Letrozole in Postmenopausal Women With Advanced Receptor-Positive Breast Cancer, Paul E. Goss, Igor N. Bondarenko, Georgiy Manikhas, Kelly Pendergrass, Wilson H. Miller, Peter Langecker, Dennis G Blanchett. Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer. This is a 59 page booklet that describes each formula that Dr. Goss and DR. Romeo Brooks have created for New Body Products and Roots Nutrition. Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats. Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer. Paul E. Goss, Alison L. Allan, David I. Rodenhiser, Paula J. Sgroi D, Carney E, Richardson E, Steffel L, Binns SN, Finkelstein DM, Shepherd LE, Kesty NC, Schnabel C, Erlander MG, Ingle JN, Porter P, Paik S, Muss HB, Pritchard KI, Tu D, Goss PE, Exemestane for Breast-Cancer Prevention in Postmenopausal Women, Paul E. Goss, James N. Ingle, Jos E. Als-Martnez, Angela M. Cheung, Rowan T. Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John A Robbins, Karen C. Johnson, Lisa W. Martin, Eric Winquist, Gloria E. Sarto, Judy Garber, Carol J. Fabian, Pascal Pujol, Elizabeth Maunsell, Patricia L. Farmer, Karen A. Gelmon, Dongsheng Tu, Harriet Richardson. F A Shepherd, Hogg-Johnson S, Fleshner N, Read Se, M. M. Fanning, Karen C. Johnson, Paul E. Goss, Coates Ra. Eduardo Paulino, Angelica Nogueira Rodrigues, Kathrin Strasser-Weippl, Jessica St. Louis, Alexandra Bukowski, Paul E. Goss. Paul E. Goss, Michael Baker, Jeremy P. Carver, James W. Dennis. Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective. Wednesday, February 2, 2011. Goss PE, Barrios CH, Bell R, Finkelstein D, Iwata H, Martin M, Braun AH, Dansey RD, Coleman RE. Proceedings of the first international conference on recent advances and future directions in endocrine therapy for breast cancer: Summary consensus statement, Aman U. Buzdar, Steven E. Come, Angela Brodie, Paul E. Goss, Matthew J. Ellis, Stephen R. D. Johnston, James N. Ingle, Adrian V. Lee, C. Kent Osborne, Victor G. Vogel, Carol S. Hart, Does treatment at the time of locoregional failure of breast cancer alter prognosis. Prez Carrin R, Alberola Candel, F. Calabresi, Michel Rt, R Santos, Delozier T, Paul E. Goss, L. Mauriac, Feuilhade F, Freue M, Branching N-Linked Oligosaccharides in Breast Cancer, Bozena Korczak, Paul E. Goss, B Fernandez, Michael Baker, James W. Dennis, Identification, cloning, and characterization of a novel human T-cell- specific tyrosine kinase located at the hematopoietin complex on chromosome 5q, Spencer B. Gibson, Bernadine Leung, Jeremy A. Squire, Mary Hill, Naomichi Arima, Paul E. Goss, David Hogg, Gordon B. Paul E. Goss, Kathrin Strasser-Weippl, Shangle Qi, Haiqing Hu, Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma, L. Lee, Melania Pintilie, David C. Hodgson, Paul E. Goss, Michael Crump, Conclusions regarding relative costutility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature, Thomas E. Delea, Jonathan Karnon, Paul E. Goss, Application of aromatase inhibitors in endocrine responsive breast cancers, Aromatase Inhibitors and Bone Health in Women With Breast Cancer, Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer, Beverly Moy, Dongsheng Tu, Joseph L. Pater, James N. Ingle, Lois E. Shepherd, Timothy J. Whelan, Paul E. Goss, Lapatinib: Current Status and Future Directions in Breast Cancer, Estrogen Receptor Pathway: Resistance to Endocrine Therapy and New Therapeutic Approaches, Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17, Edith A. Perez, Robert G. Josse, Kathleen I. Pritchard, James N. Ingle, Silvana Martino, B. Findlay, Tamara N. Shenkier, Richard Tozer, Michael J. Palmer, Lois E. Shepherd, Shifang Liu, Dongsheng Tu, Paul E. Goss. Examination of POU homeobox gene expression in human breast cancer cells. His later successes with MotorWeek only further solidified his star power in the car world. Dr. Sharita learned iridology from her father Dr. Paul Goss, who is a world renowned master iridologist, and naturopath. Dr David Goss is an orthopaedic spine surgeon in Chesapeake and Suffolk, VA. Dr Goss has been extensively trained in a vast array of surgical and non-surgical techniques, to treat all spinal disorders and injuries. He is from . Liedke, Paul E. Goss, Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole, Paul E. Goss, JN Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Robert B. Livingston, Nancy E. Davidson, E. A. Perez, Yanin Chavarri-Guerra, David Cameron, Kathleen I. Pritchard, Timothy J. Whelan, Lois E. Shepherd, Dongsheng Tu, Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial, Paul E. Goss, Ian E. Smith, Joyce O'Shaughnessy, Bent Ejlertsen, Manfred Kaufmann, Frances F. Boyle, Aman U. Buzdar, Pierre Fumoleau, William W. Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I. Pritchard, Deborah Lindquist, Yanin Chavarri-Guerra, Gursel Aktan, E. Rappold, L. S. Williams, Dianne M. Finkelstein, Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study, Kishor M. Wasan, Paul E. Goss, P. Haydn Pritchard, Lois E. Shepherd, Dongsheng Tu, James N. Ingle, Breast cancer in Mexico: a growing challenge to health and the health system, Yanin Chavarri-Guerra, Cynthia Villarreal-Garza, Pedro E.R. Determinants of preferences for starting extended adjuvant letrozole (L) in postmenopausal women following five years of tamoxifen. Your Price: $1.00. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats. Laura R. Parham, Linda P. Briley, Karen S. King, Julie Byrne, E. Rappold, Paul E. Goss, Colin F. Spraggs, Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy, TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer, Steven J. Isakoff, Erica L. Mayer, Lei He, Tiffany A. Traina, Lisa A. Carey, Karen Krag, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Steven E. Come, Kirsten Timms, Anne Renee Hartman, Darrel R. Borger, Dianne M. Finkelstein, Judy Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, Leif W. Ellisen. This information is for educational purposes only and should not be taken as . Characterization of a novel silencer element in the human aromatase gene PII promoter. The effects of atamestane, toremifene, and atamestane plus toremifene compared to letrozole on bone, serum lipids and uterus. This gave him the true meaning of self. In this rural setting he received the basis for an international education. Putative growth characteristics of micrometastatic breast cancer. Aromatase inhibitors and their potential clinical significance. Todd, Timothy Winton, M. Rubinger, Else Johansen, A K Stewart, Frances A. Shepherd, Paul E. Goss, Ellen Warner, Denis Bailey, Michael Baker, Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: Preliminary report of a phase II study, Paul E. Goss, Frances A. Shepherd, Scott Jg, Ellen Warner, Michael Baker, D M Sutton, H A Farquharson, Buick S, S. Sutcliffe. Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Summary of aromatase inhibitor trials: the past and future. Endometrial Cancer in Brazil: Preparing for the Rising Incidence. Robert NJ, Goss PE, Ingle JN, Tu D, Shepherd L, Palmer M, Pater J. Bone loss with exemestane: Is the jury still out? Asa Hilliard, Dr. Paul Goss, etc. Dr. Akua Gray, ND Naturopath Instructor at A Life Of Peace Wellness Education Institute, Inc. . I found myself transforming after only seven days of Vegetarian food, fresh juices and smoothies. Extragonadal germ cell tumors. An intracardiac mass presenting as atrial fibrillation in a patient with testicular carcinoma. Goss PE, Ingle JN, Ales-Martinez J, Cheung A, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson K, Martin L, Winquist E, Sarto G, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H. A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Hematology and Oncology Specialist Internist PX Score: Patient Experience: 5.0/5 (8) Boston, MA Dr. Goss is a hematology and oncology specialist in Boston, MA. Breast cancer prevention--clinical trials strategies involving aromatase inhibitors. MENU. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Loving longtime partner of 29 years to Wanda Ceresia; loving father of Tony (Brenda) Goss, Angela (Gil) Grooms, and Douglas Goss; dear grandfather of Anthony, Brendan, Isabella Goss; Geddy (Cyd) Cary-Avery, Bowie Avery, and Trinity Avery; and Luke Goss; dear brother of Sylvia (Gene) Stamm, Joseph Granville (Linda) Goss, Warren (Mae) Goss, Dean (Susan . Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus. Denosumab and the current status of bone-modifying drugs in breast cancer. Joseph L. Pater, Paul E. Goss, Ralph M. Meyer. Sonali Jindal, Nathan D. Pennock, Duanchen Sun, Wesley Horton, Michelle K. Ozaki, Jayasri Narasimhan, Alexandra Q. Bartlett, Sheila Weinmann, Paul E. Goss, Virginia F. Borges, Zheng Xia, Pepper Schedin. Neerav Shukla, Stephen S. Roberts, Mollah O. Baki, Qazi Mushtaq, Paul E. Goss, Ben Ho Park, Gunes Gundem, Ken Tian, Heather Geiger, Kristie Redfield, Gerald Behr, Ryma Benayed, Ahmet Zehir, Jaclyn F. Hechtman, Robert B. Darnell, Elli Papaemmanuil, Marc Ladanyi, Nora Ku, Andrew L. Kung, Jos Baselga, Alexander Drilon, David M. Hyman. Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer. Shopping Cart - 0 Items; 201 547-3520 . Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. Junmei Cairns, Krishna R. Kalari, James N. Ingle, Lois E. Shepherd, Matthew J. Ellis, Paul E. Goss, Poulami Barman, Erin E. Carlson, Barbara Goodnature, Matthew P. Goetz, Richard M. Weinshilboum, Huanyao Gao, Liewei Wang. I had the pleasure last Jun 2014 , to spend a week at Dr. Paul Goss's Eden Ranch, located in Douglas Arizona. The New Body Products Company was established in 1976 by Dr. Paul Goss, who is also its president. Become a New Body distributor and Herbal Consultant: CLICK HERE I'm happy to give you . Liedke, Felicia Marie Knaul, Alejandro Mohar, Dianne M. Finkelstein, Paul E. Goss. Preventing Relapse Beyond 5 Years: The MA.17 Extended Adjuvant Trial. 3. Steven E. Come, Aman U. Buzdar, James N. Ingle, Stephen R. D. Johnston, Angela Brodie, R. Charles Coombes, William R. Miller, Kathleen I. Pritchard, Eric P. Winer, Jo Anne Zujewski, Paul E. Goss. Paul E. Goss, Lynn Schwertfeger, Martin E. Blackstein, Neill A. Iscoe, Robert J. Ginsberg, William J. Simpson, Donald P. Jones, Frances A. Shepherd, A Phase I Study of Swainsonine in Patients with Advanced Malignancies, Paul E. Goss, Jose Baptiste, Berny Fernandes, Michael Baker, James W. Dennis. Jing Xu, Tanya Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss, Beow Y. Yeap, Bruce A. Chabner, Steven J. Isakoff. Update on the use of letrozole in breast cancer. Tongue scraping is an easy routine to remove food and bacteria from the surface of the tongue. Mark down these key Medicare enrollment dates. Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. He also leads large practice changing clinical . Andre Lopes, Jessica St. Louis, Marcelo Luiz Balancin, Anglica Nogueira-Rodrigues, Luana Carolina Ferreira Fiuza Silva, Eduardo Paulino, Bianca Silveira S, Alexandra Bukowski, Edison Mantovani Barbosa, R. L.R. 5 (1 rating) Leave a review. The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment. Mirza Jacqueline Alcalde-Castro, Enrique Soto-Perez-de-Celis, Alfredo Covarrubias-Gmez, Sofa Snchez-Romn, Paulina Quiroz-Friedman, Africa Navarro-Lara, Wendy Alicia Ramos-Lopez, Mara Luisa Moreno-Garca, Sergio Contreras-Garduo, Viridiana Perez-Montessoro, Paul E. Goss, Yanin Chavarri-Guerra, Sarah Barry Lincoln, Enrique Soto-Perez-de-Celis, Yanin Chavarri-Guerra, Alfredo Covarrubias-Gmez, Mariana Navarro, Paul E. Goss. Doctor has top marks across all patient-rated categories. Paul Goss is an internist established in Boston, Massachusetts and his medical specialization is Internal Medicine with a focus in hematology & oncology . Angela M. Cheung, George Tomlinson, Paul E. Goss. He received . Paul E. Goss, Michael Jarman, Leslie J. Griggs. The Wall Street Journal interviews Paul Gross, M.D., about the growing emphasis medical schools are placing on humanities, including courses in writing and literature, in order to help produce physicians better able to provide sensitive personal care. Dr. Paul Goss has touched the lives of thousands of patients, students and practitioners of natural remedies around the world. Goss grew up in the small rural community of Alcoa, Tennessee. High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases, Rick Abraham, Tracy Nagy, Paul E. Goss, Michael Crump. Anglica Nogueira-Rodrigues, Alexandra Bukowski, Eduardo Paulino, Jessica St. Louis, Adriana Barrichello, Cinthya Sternberg, Markus A. C. Gifoni, Silvana Luciani, Paul E. Goss. Moy, B., Kirkpatrick, P., Kar, S., Goss, P. Breast cancer in women < or = 35 years: review of 1002 cases from a single institution. Tianru Jin, Donald R. Branch, Xiaoyun Zhang, Shangle Qi, Bruce Youngson, Paul E. Goss, Rivizor A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure, Paul E. Goss, David Walde, R. De Coster, C. Langenaeken, J. Bruynseels. Paul E. Goss, Shangle Qi, Angela M. Cheung, Haiqing Hu, Maria Mendes, Kenneth P.H. Tips for Relieving Daily Stress and Calming Down, Best Continuing Care Retirement Community (CCRC), Best Medicare Advantage Plan Companies 2023, Best Medicare Part D Prescription Drug Plan Companies 2023. Paul Goss, Ph.D., MBBCH. Funny. New. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target? Costa, Paul E. Goss, Enrique Soto-Perez-de-Celis, Yanin Chavarri-Guerra, Tania Pastrana, Rossana Ruiz-Mendoza, Alexandra Bukowski, Paul E. Goss. The Natural Way by Dr. Paul Goss. Aromatase inhibitors and the treatment of breast cancer. Dr. Paul Goss, founder and president of NEW BODY PRODUCTS, was the eighth child of ten born to Sam and Annie Goss of Canton, Georgia. Rossana Ruiz, Kathrin Strasser-Weippl, Diego Touya, Carmen Herrero Vincent, Abraham Hernndez-Blanquisett, Jessica St. Louis, Alexandra Bukowski, Paul E. Goss, Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study, M. Higgins, Giuseppe Curigliano, Vronique Diras, Sherko Kuemmel, G. Kunz, Peter A. Fasching, Mario Campone, Thomas Bachelot, P. Krivorotko, Steve Chan, A. Ferro, Lee S. Schwartzberg, Marc Gillet, P. M. De Sousa Alves, V. Wascotte, F. F. Lehmann, Paul E. Goss. Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancer. 1. Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. Gross notes that doctors rarely have an opportunity to talk with patients about their lives and their . Patterson, Ronald Feld, Paul E. Goss, F.G. Pearson, T.J.R. "This is the beginning of a new era in breast-cancer therapy," says Dr. Paul Goss, of Princess Margaret Hospital in Toronto, who directed the project. J. Improving access to high-cost cancer drugs in Latin America: Much to be done. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes. Jonathan Karnon, Thomas E. Delea, Stephen R. D. Johnston, Robert A. Smith, J. Brandman, Jennifer Sung, Paul E. Goss. Extended adjuvant endocrine therapy in breast cancer: current status and future directions. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Karina J. Matissek, Maristela L. Onozato, Sheng Sun, Zongli Zheng, Andrew Schultz, Jesse Lee, Kristofer Patel, Piiha Lotta Jerevall, Srinivas Vinod Saladi, Allison MacLeay, Mehrad Tavallai, Tanja Badovinac-Crnjevic, Carlos H. Barrios, Nuran Bese, Arlene Chan, Yanin Chavarri-Guerra, Marcio Debiasi, Elif Demirdogen, Unal Egeli, Sahsuvar Gokgoz, Henry L. Gomez, Pedro Er Liedke, Ismet Tasdelen, Sahsine Tolunay, Gustavo Werutsky, Jessica St. Louis, Nora Horick, Dianne M. Finkelstein, Long P. Le, Aditya Bardia, Paul E. Goss, Dennis C. Sgroi, A. John Iafrate, Leif W. Ellisen, Patient Navigation to Improve Access to Breast Cancer Care in Brazil, Alexandra Bukowski, Sandra Gioia, Yanin Chavarri-Guerra, Enrique Soto-Perez-de-Celis, Jessica St. Louis, Eduardo Paulino, Anglica Nogueira-Rodrigues, Paul E. Goss. Gosar Once Again Introduces Resolution to Terminate COVID-19 National Emergency. Goss PE, Barrios CH, Chan A, Chia SKL, Delaloge S, Ejlertsen B, Ingle JN, Moy B, Iwata H, Holmes FA, Mansi J, Von Minckwitz G, Han L, Thiele A, Agrapart V, Freyman A, Truscello J, Berkenblit A, Finkelstein D, A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women, Tessa Cigler, Harriet Richardson, Martin J. Yaffe, Carol J. Fabian, D. Johnston, JN Ingle, E. Nassif, R. L. Brunner, M. E. Wood, J. L. Pater, Haiqing Hu, Shangle Qi, Dongsheng Tu, Paul E. Goss, Aromatase immunoreactivity is increased in mammographically dense regions of the breast, Celine M. Vachon, Hironobu Sasano, Karthik Ghosh, Kathleen R. Brandt, David A. Watson, Carol Reynolds, Wilma L. Lingle, Paul E. Goss, Rong Li, Sarah E. Aiyar, Christopher G. Scott, V. Shane Pankratz, Richard J. Santen, James N. Ingle, Does tumour dormancy offer a therapeutic target, Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women, Andrea Z. LaCroix, Trevor J. Powles, C. Kent Osborne, Kevin Wolter, John R. Thompson, David D. Thompson, D. Craig Allred, Roisin Armstrong, Steve Cummings, Richard Eastell, Kristine E. Ensrud, Paul E. Goss, Lee Andrew George, Patrick Neven, David M. Reid, Madelyn Curto, Slobodan Vukicevic, Genome-wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors, James N. Ingle, Daniel J. Schaid, Paul E. Goss, Mohan Liu, Taisei Mushiroda, Judy Anne W. Chapman, Michiaki Kubo, Gregory D. Jenkins, Anthony Batzler, Lois E. Shepherd, Joseph L. Pater, Liewei Wang, Matthew J. Ellis, Vered Stearns, Daniel C. Rohrer, Matthew P. Goetz, Kathleen I. Pritchard, David A. Flockhart, Yusuke Nakamura, Richard M. Weinshilboum.